In coeliac disease, an increased risk of malignancy and increased general mortality have been found in a British8 but not in a recent Finnish study.9 In DH, an increased incidence of malignancy and especially of lymphoma has been reported in studies from England' 0 1 and Sweden.12 In the Swedish study no data were available on the treatment given to the patients. Moreover, the British series included DH patients taking a gluten containing diet, which has been shown to increase the incidence of malignancy in patients with coeliac disease.8
ofmalignancy and survival ofpatients with dermatitis herpetiformis and compared the results with those seen in patients with coeliac disease or in the general population. Patients-A total of 305 adult patients with dermatitis herpetiformis diagnosed at the University Hospital of Tampere in 1970-1992 were studied. Most patients started a gluten free diet and at the end of the study 93% of the patients were adhering to the diet. A control group comprised 383 adult patients with coeliac disease, 81% of them adhered to a gluten free diet, 6% had a normal diet, and in 13% the diet history remained unknown. Methods-The occurrence of malignant diseases and survival of the patients were assessed up to the end of 1993. Standardised incidence ratios (SIR) with 95°/0 confidence intervals were used for the malignant diseases. The survival of the patients was In coeliac disease, an increased risk of malignancy and increased general mortality have been found in a British8 but not in a recent Finnish study.9 In DH, an increased incidence of malignancy and especially of lymphoma has been reported in studies from England' 0 1 and Sweden.12 In the Swedish study no data were available on the treatment given to the patients. Moreover, the British series included DH patients taking a gluten containing diet, which has been shown to increase the incidence of malignancy in patients with coeliac disease.8
In this study, we examined the occurrence of malignancy and survival in a DH patient cohort treated mainly with a gluten free diet. The findings were compared with those in patients with coeliac disease to find out whether there are any differences between these two closely associated gluten sensitive diseases. The occurrence of malignancy and survival was compared also with the general population.
Methods

Patients
The study cohort included all 305 consecutive patients with DH diagnosed at the Department of Dermatology, Tampere University Hospital, in 1970-1992. The diagnosis of DH was based on the clinical picture and on the finding of pathognomic granular IgA deposits in the epidermal-dermal junction by direct immunofluorescence examination. Small bowel biopsy specimens were taken from 237 (78%) patients with DH and the findings were graded as subtotal or partial villous atrophy and as normal mucosa. The patients were prescribed dapsone and most patients adhered to a gluten free diet at the same time. Since 1978, the patients with DH were routinely followed up at (Table II) . Table III shows all malignant diseases occurring both before and after the diagnosis of DH. Four patients with DH contracted malignancy before the diagnosis. One patient with DH contracted two malignant diseases during the follow up: prostatic cancer and penile lymphoma. Six of 13 patients with DH who contracted a malignancy during the follow up were taking a normal diet and seven patients were adhering to a gluten free diet (Table III) . Survival Thirteen (4.3%/o) patients with DH and 31 (8.1%) with coeliac disease died during the follow up period. The 10 and 15 year survival rates of both female and male patients with DH tended to exceed those of the general population (Table IV) . The survival rates of the patients with coeliac disease did not differ significantly from the rates seen in the general population.
Discussion
In this study, a cohort of 305 patients with DH sampled during 23 years was examined for malignancy and survival. The patient series is larger than any previous study from one centre and none of the patients were lost to follow up.
We were also able to compare the results with those seen in 383 patients with coeliac disease. In contrast with the present results, a fourfold increased cancer incidence was found in a recent study of 152 DH patients followed up in London in 1971-1985.10 One reason for the discrepancy could be the differences in the treatment. In our study, 93°/O of the DH patients were treated with a gluten free diet compared with 38% of the British patients. These findings imply that similar to coeliac disease,8 gluten free diet also seems to protect against the development of malignancy in DH patients.
Two previous studies in DH have shown 100-fold and 5A4-fold risks of developing lymphoma.'1 12 We found a 10-fold, statistically significant risk based on four observed cases of non-Hodgkin's lymphoma. Three of the DH patients were adhering to a gluten free diet, but in two patients the duration of the diet was less than five years, which is probably too short a period to play any protective part in the development of lymphoma.8 In our four patients with lymphoma, three presented with abnormal small bowel villous architecture and one patient with normal mucosa. This implies that a normal small bowel mucosa in DH does not protect from lymphoma. Despite this, there are two main reasons why we recommend that a small bowel biopsy specimen is taken from patients with DH before starting the gluten free diet treatment. Firstly, most DH patients have no gastrointestinal symptoms and therefore, their motivation to follow the diet is much better if they know that the small bowel mucosa is damaged. Secondly, if some gastrointestinal symptoms appear during the diet or if the rash does not respond adequately to the gluten free diet treatment, it is helpful to know how severely the jejunal mucosa was damaged before the diet was started. We do not routinely take control small bowel biopsy specimens from patients with DH, because the resolution of the rash is a good indicator for strict adherence to gluten free diet treatment. In this study the dermatological outcome was good and similar to that reported in a previous British study. '3 Half of our patients with DH could stop using dapsone and one third of the patients could significantly reduce the daily dose of dapsone during the gluten free diet treatment.
The general mortality of our patients with DH was not increased, a result that is in agreement with that reported by Swerdlow et al.10
The longterm survival rates of our patients with DH were slightly but significantly higher than those of the general population. One reason for this could be that the patients adhered strictly to a gluten free diet and visited regularly a special outpatient clinic.
In conclusion, this study showed that the patients with DH had a significantly increased incidence of non-Hodgkin's lymphoma. The overall incidence of other malignant diseases was not increased, however, and there was no increased general mortality.
